# Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype

> **NCT05314374** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 35 (actual)

## Conditions studied

- Obesity
- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Ileocolonic-release conjugated bile acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05314374
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-12
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-11-13
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05314374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05314374, "Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05314374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*